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Abstract
HyperArc is a radiation therapy planning technique using stereotactic radiosurgical doses
delivered via single isocenter volumetric modulated arcs (VMAT) for multi-lesion brain cancer.
Due to the nature of these types of treatments it is imperative that the proper quality assurance is
completed to ensure the safety of the patient. Geometric limits were assessed using a dose
volume histogram (DVH) and known rotational errors of theoretical lesions of different
dimensions and lengths from the isocenter. Dosimetric comparisons were evaluated using an ion
chamber and Gafchromic EBT-XD film and portal dosimetry. The conclusions from these
investigations were that patient rotation will result in a loss of target coverage, which is
emphasized for smaller targets and isocenter placement farther away from the lesion. The use of
a six degree of freedom (6DoF) couch for set-up and surface tracking during beam delivery
reliably positions patients to avoid positioning errors that would degrade treatment outcomes.
HyperArc is a user-friendly clinical tool that can be confidently used in a clinical setting when
the limitations are well known to the user.
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Introduction
Stereotactic radiosurgery (SRS) has been utilized in the treatment of intracranial targets
for many decades. Prior to this point, the utilization of radiation in the treatment of cancer
involved the lesion and an appreciable amount of healthy tissue (Mitchell et al., 2022). This is
problematic for any treatment site but has greater significance when treating the brain with
radiation. The original intent of SRS was to treat benign disease with a high dose of radiation in
a single treatment using a specialized treatment machine called a Gamma Knife (Khan &
Gibbons, 2014). This has now evolved into fractionated stereotactic radiotherapy (SRT) with
wider availability because of its delivery using a linear accelerator. This is an important
development when metastatic disease to the brain outnumbers primary brain tumor diagnosis
10:1 (Saha et al., 2013).
Many clinical advances have made this type of treatment less cumbersome for radiation
oncology staff to deliver, while continuing to uphold the most accurate dosimetric outcomes for
patients. One of the newest products to aid in the treatment of patients with brain tumors is
produced by Varian Medical Systems and is entitled HyperArc (Popple et al., 2021). HyperArc
has the ability to create streamlined SRS treatment plans that utilize a single isocenter,
volumetric modulated arc-therapy (VMAT) to treat single or multiple brain lesions
simultaneously with automated planning tools. The nature of SRS plans, specifically plans where
the HyperArc workflow is utilized, necessitate that the treatment plan, patient set-up,
immobilization, and monitoring is completed with the highest precision.
St. George Regional hospital acquired licensure for this product in April of 2021 for its
use on the Varian TrueBeam linear accelerator. SRS procedures have been done in the St.
George clinic with the highest accuracy since 2010. Until recently these treatments were
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delivered with multiple different isocenters that received the entire prescription dose. Using
multiple isocenters per treatment was a restricting and cumbersome process for the radiation
oncology staff. The addition of HyperArc alleviated many time related constraints from the
treatment planning process to the actual time the patient spent on the treatment table, as will be
discussed later in this paper. Long standing SRS treatment techniques are no longer utilized with
HyperArc. This created questions about the usability of this product and if there were limitations
to which patients could be treated using the HyperArc workflow. In order to better assess this
tool geometric and dosimetric aspects were examined to better understand the possible
limitations and create more confidence with the HyperArc treatment functionality.

Stereotactic Radiosurgery
History
Stereotactic radiosurgery was first introduced in the 1950s by a neurosurgeon named Lars
Leksell (Khan & Gibbons, 2014). Leksell proposed the use of focused pencil beam radiation
emitted from Cobalt-60 sources to noninvasively treat diseased locations of the brain (Petti et al.,
2021). This treatment unit was called the Gamma Knife and is still widely accepted as the gold
standard machine for SRS treatments and offers an alternative treatment method to patients who
would otherwise only be offered a surgical removal option or whole brain radiation treatment
(Vergalasova et al., 2019). The Gamma Knife is a simple machine with mechanical movements
restricted to a single couch top and a semicircular helmet that, for modern units, houses 192 60Co
sources that are able to produce three different field sizes focused to the unit center point. The
target in the brain is then positioned to this point in space for treatment using a stereotactic frame
that is secured to the patient’s skull with steel pins. This ensures the delivery of geometrically
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precise treatments (Chen & Girvigian, 2005). Although the Gamma Knife is the benchmark for
SRS treatments it does have disadvantages: its simplistic design only allows for the treatment of
intracranial lesions and its use of decaying radioactive sources can result in lengthy treatment
times and are costly to replace every five to ten years.
Leksell's Gamma Knife was the first dedicated SRS treatment machine. The linear
accelerator (LINAC) was able to be adapted in the 1980s to deliver SRS treatments as well
(Benedict et al., 2008). Instead of using radioactive sources, a LINAC accelerates electrons at a
tungsten target to produce x-ray radiation that is then collimated into a beam of radiation (Khan
& Gibbons, 2014). The early LINAC based SRS treatments utilized an exchangeable tertiary
collimator with a machined circular hole that was mounted to the gantry head and was used in
conjunction with intersecting beams to obtain a precision treatment comparable to the Gamma
Knife (Trifiletti et al., 2019). These tertiary collimators minimize the penumbra and produce a
rapid dose fall off outside of the target volume and come in diameters ranging from 4 to 40 mm.
This technique aligned a patient to the machine isocenter using a stereotactic frame similar to
that of gamma knife treatments to position and immobilize the skull. Treating irregularly shaped
lesions using Gamma Knife or cones requires the use of different sized apertures to deliver a
beam that closely resembles the shape of the lesion, this is called sphere packing (De Ornelas et
al., 2021). Overtime LINAC computer systems and mechanical features became more reliable in
their ability to deliver targeted radiation using MLCs (Knisely & Apuzzo, 2019). The use of
MLCs allowed for the treatment of irregularly shaped lesions with a single isocenter. By the
early 1990s, LINACs had the ability to deliver intensity modulated radiation beams in an arcing
geometry increasing the conformality of LINAC-based SRS with MLCs. Although the
accessibility of SRS treatments improved with LINAC based delivery, treatment times were on
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the order of twenty minutes per target for multi-isocenter treatments (Clark et al., 2012) which
limited the number of targets that could be treated in a clinically reasonable time frame.
The utilization of LINAC-based SRS did not come without skepticism. These doubts led
to advancements that focused on the current knowledge of radiobiology and hypo fractionated
treatments (Knisely & Apuzzo, 2019). The understanding that fractionated treatments would
decrease normal tissue toxicity but continue to produce high amounts of tumor cell killing made
it a viable option for the treatment of metastatic disease to the brain. The fractionation dosages
accepted depend on the size of the targets needing treatment. Typically, targets that have a
diameter smaller than one centimeter can receive up to 24 Gy in a single fraction (Shaw et al.,
2000). As the target size increases the prescription dose decreases and the likelihood for a
fractionated treatment becomes more prevalent.
There were two separate advancements that made fractionated SRS treatments possible.
The first was the use of a noninvasive thermoplastic facemask which was able to reposition the
patient in the similar geometric location to the initial set up determined in the simulation process
for each fraction. The second was the addition of image guided radiation therapy (IGRT). On
board imaging included a kV x-ray radiation source and detector and a MV detector. These
devices allowed for images to be taken prior to irradiation to determine where the patient needed
to be positioned that day to most closely resemble the original planning CT images. A practical
planning approach using non-coplanar beams for single isocenter LINAC-based SRS for one or
more brain lesions was published by Clark et. al, in 2012. The proposed process was useful for
creating plans for single target single isocenter plans but speculated that when multiple targets
are present a multi-target single isocenter approach to treatment would replace the multiisocentric plans. This was a drastic difference from the original SRS delivery method where the
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entire prescription dose was delivered to each isocenter. With this new technique each target
would receive the prescription dose off-axis from the isocenter.
That prediction has been correct; single isocentric treatments have gained immense
popularity within the last few years for the treatment of brain metastasis. Again, this new
approach to SRS delivery was coupled with distrust over the efficacy for this delivery approach.
Using the previously discussed planning method proposed by Clark et. al, plans with two to four
non-coplanar arcs produced clinically acceptable results for multiple targets treated with a single
isocenter. These plans had a rapid dose fall off and high dose regions that conformed to the target
volume. The drawback of utilizing a single isocenter was the low dose bridging in between
targets that is unavoidable, but there is also a significant decrease in treatment time that makes
this process the most clinically acceptable for patients that prior to the use of this methodology,
would have had only the option of whole brain radiotherapy (Nath et al., 2010).

HyperArc
Varian HyperArc™ high-definition radiotherapy is a new feature option for intracranial
MLC-based SRS treatments for clinics equipped with an Eclipse treatment planning system and
an Edge or TrueBeam linear accelerator (Popple et al., 2021). HyperArc implements a fixed
geometry non-coplanar VMAT SRS treatment technique in such a way that all possible beam
trajectories can be applied to a single isocenter plan to obtain the best dose coverage to a single
or multiple target. HyperArc is unique in the way that it automates the workflow from treatment
planning to delivery and is able to produce high quality treatment plans more efficiently.
Besides having the correct Varian technology and the HyperArc license, it is necessary to
have the required immobilization devices to unlock the full automated experience. The CT
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simulation process is something all patients that are being treated with radiation must do. It is
during this process that an optimal patient set-up is determined using a multitude of site-specific
devices. HyperArc SRS treatments require an Encompass couch top from Qfix and an
Encompass open faced clamshell facemask (De Ornelas et al., 2021). There has been a lot of
investigation into the integrity of a proper immobilization device for HyperArc SRS that requires
the most precision alignment. Ohira et al., (2022) investigated the use of full-face clamshell SRS
masks compared to open faced clamshell SRS masks for patient stability and found that there
was no difference in stability. This finding supports the immobilization of the open face
Encompass mask, shown in Figure 1.
If the proper devices are utilized during the CT simulation process, a HyperArc plan will
be able to be created in Eclipse. Using the contoured structure set, the HyperArc plan will
automatically place an isocenter and determine the optimal gantry, collimator, and couch rotation
for the best target coverage that will minimize the low dose spillage in between targets for multitarget plans. Along with determining the best beam trajectories, the HyperArc algorithm also
accounts for patient location and avoids geometries that could have possible collisions with the
patient or the couch.

6

Figure 1. Set-up of STEEV phantom with the proper HyperArc immobilization devices.

Once the optimal machine settings are in place, the optimizer is used to produce a rapid
dose fall off outside of each target. Non HyperArc SRS planning techniques often use other
contour volumes, such as rings, to achieve the optimal falloff. With HyperArc these structures
are not necessary to produce a clinically acceptable treatment plan. There are two HyperArc
specific features in the optimizer, the SRS normal tissue objective (SRS NTO) and the
Automatic Low Dose Objective (ALDO). The SRS NTO oversees dose falloff and dose bridging
between targets (Snyder et al., 2021). If there are multiple targets and dose bridging is necessary,
the SRS NTO will try to keep the dose between targets below seventeen percent of the
prescription dose. A large concern with multi-target single isocenter plans is the low dose
spillage because of its link to radiation necrosis (Goldbaum et al., 2019). For a single fraction
SRS plan the volume of the brain receiving 12 Gy is a widely used metric to quantify the
likelihood of a patient developing radio-necrosis. Many different studies have shown that an SRS
7

treatment plan should have a total volume of 12 Gy dose less than 10 cubic centimeters to try and
alleviate significant radio-radio-necrosis (Loo et al., 2021). Fractionation of SRS treatments
changes the determining factors for brain toxicity. Milano et al. (2021), pooled data from 51
different reports from 1995 to 2018 and determined that the risk of radio-necrosis for a three- and
five- fraction SRS treatments was best assessed using the volume of the brain, including the
target volume, receiving 20 Gy and 24 Gy, respectively. Keeping these dose volumes below 20
cubic centimeters reduced the risk of radio-necrosis to below ten percent. Because HyperArc can
find the optimal beam trajectories, it has been shown to produce plans with a rapid dose fall off
around the target and a significant reduction in the volume of the brain outside of the target
receiving low dose (Ruggieri et al., 2018).
The ALDO is a single normalization tool that has a goal of getting all target volumes a
ninety-eight percent prescription dose coverage (Ho et al., 2021). ALDO does this by bundling
the target DVHs so that the same prescription dose level is reached. It also automatically adjusts
the priority to the targets during the optimization making it much more user friendly. If there is a
lack of target coverage there is a high risk of recurrence. Per the RTOG radiosurgery guidelines,
a target with complete coverage of the ninety percent prescription line is accepted as per protocol
(Shaw et al., 1993). While a target not covered by eighty percent of the prescription dose is a
major deviation. It is important to know that these are guidelines and, depending on
circumstance, have tradeoffs for other planning constraints.
Another unique feature of HyperArc is the treatment plan evaluation tools provided to the
user. A dose volume histogram (DVH) analysis is a common way to evaluate plan quality. Along
with this there have been other metrics developed and used for many years to gauge the
effectiveness of an SRS treatment plan. Four different indices are calculated and reported for the

8

dose statistics of the target volume; they are the Radiation Therapy Oncology Group (RTOG)
conformity index (CI), Paddick CI, the International Commission on Radiation Units and
Measurements (ICRU) Report 83 heterogeneity index (HI), and gradient index (GI). RTOG
Conformity index was proposed in 1993 to evaluate how well the dose distribution covers the
target volume. It can be calculated using the following equation:
𝐶𝐼𝑅𝑇𝑂𝐺 =

𝑉𝑅𝐼
𝑇𝑉

(1)

where VRI is the volume covered by the fifty percent prescription dose and TV is the total
volume of the target. The RTOG protocol has an ideal output between one and two and anything
above eludes to healthy tissue being irradiated and a value below concludes there is under
coverage of the target. The simplicity of calculating the RTOG CI has made it a widely used
tool, but it has been criticized for not accounting for the overlap of the volume receiving the
prescription dose and the target volume. Figure 2 demonstrates how a per protocol plan can have
many different dose distributions that meet the required value of one while visually not covering
the necessary target volume. To try and correct for this criticism Paddick et al. developed a
different CI protocol.
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Figure 2. Various possibilities when the RTOG CI is equal to 1 (Feuvret et al., 2006).

The Paddick CI accounts for the geometric overlap of the target and the prescription dose
mathematically eliminating false scores produced by the RTOG protocol. It is defined as:
𝐶𝐼𝑃𝑎𝑑𝑑𝑖𝑐𝑘 =

2
𝑇𝑉𝑃𝐼𝑉

(𝑇𝑉 × 𝑉𝑅𝐼 )

(2)

where TVPIV is the target volume covered by the prescription dose, TV is the total target volume,
and VRI is the total volume covered by fifty percent of the prescription dose (Stanley et al.,
2011). Just like the RTOG CI, all the necessary values for these metrics can be extracted from
the DVH produced by the treatment planning system. A per protocol plan will have a value of
one with deviations resulting in scores less than one. A comparison of the RTOG and Paddick CI
was done by Stanley et al. in 2011 with the conclusion that neither metric was able to produce
results independent of target volume for regions smaller than one cubic centimeter, but if a DVH
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is available, the Paddick CI provides the same information as the RTOG CI dose. As shown in
Figure 3, the dose becomes less conformal as the isocenter distance from the target increases for
both indices. It is also evident that, for the evaluated plans, the RTOG CI typically overestimates
the conformity of dose to the target. It is worth noting that, for the ten-centimeter distance, the 1
cm MLC leaves are utilized to deliver dose to the target which is one of the contributing factors
for the decreased conformality (Figure 4).

Figure 3. Comparison between the RTOG and Paddick CI values for increasing target to
isocenter distances.
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Figure 4. Depiction of an MLC pattern for a target to isocenter distance of 10 cm.

Another dose statistic HyperArc reports for the target is the ICRU Report 83
Homogeneity Index. This HI is responsible for assessing the uniformity of absorbed dose within
the target volume and is given by
𝐻𝐼 =

𝐷2% − 𝐷98%
𝐷50%

(3)

where D2% is the near minimum absorbed dose, D98% is the near maximum absorbed dose and
D50% gives the median value of absorbed dose to the target (Hodapp, 2012). A perfectly
homogeneous outcome would produce a HI value of zero. ICRU Report 83 suggests utilizing
these near maximum and minimum values because of the constraints placed on dose falloff
outside of the target volume for SRS treatment plans. For instance, a D100% may not accurately
represent absorbed dose to the target because of the high dose gradient at the edge of a target
volume. Although it is important to make sure a lesion is completely covered by the desired
prescription dose, it is equally important that there is adequate fall off to avoid radio-necrosis to
healthy brain tissue, as it was previously discussed. Upon the evaluation of the heterogeneity
index for the HyperArc produced treatment plans utilized to assess geometric limitations, the HI
value stayed consistent as the isocenter and target became more distant (Figure 5). Also, the
12

median value of 0.37 shows that the target coverage lacked uniformity as to be expected for an
SRS plan.

Figure 5. Heterogeneity index values for targets at increasing distance from isocenter.

The Gradient Index is an assessment of how fast the dose falls off outside of the
treatment volume. This metric is simply defined by
𝐺𝐼 =

𝑉50%
𝑉100%

(4)

where the V50% is the volume of the fifty percent isodose line and V100% is the volume of the
prescription isodose line (Clark et al., 2012). This index is important for the assessment of the
low dose spillage into healthy brain tissue. Typically for SRS plans this occurs within a few
millimeters (Menon et al., 2018). An ideal value of the GI would be one. Generally, targets with
smaller volumes produce higher GI outcomes than larger targets. Evaluation of plans with
increased isocenter and target distances indicates that, as the target-to-isocenter distance
increases, the dose falloff is less steep (Figure 6). Referring to Figure 4, the use of larger MLC
leaves as the target gets farther from the isocenter produces a more gradual dose fall off.
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Figure 6. Gradient index values for targets at increasing distance from isocenter.
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As previously mentioned, integration into the planning algorithms enables the system to
predict patient clearance during treatment. Accounting for the patient protection zone upon
treatment planning permits the use of automated delivery of all fields, greatly reducing the total
treatment time. Some SRS treatment techniques, e.g. cones, require the radiation therapists to
enter the treatment vault and manually move the gantry and couch prior to the desired locations
prior to beam delivery in order to prevent collisions. This process could take several minutes and
must be completed for each field. Automated delivery is part of the HyperArc license and is not a
feature for non-HyperArc SRS delivery. To have the most confidence using the automated
feature, as with any SRS treatment, patient alignment is the key component. Using the
immobilization devices created in the CT simulation process, a cone-beam computed
tomographic image and a six degrees of freedom (6DoF) couch, patients are able to be
repositioned in such a way that emulates the target location used for treatment planning and a
precision treatment is able to be delivered (Benedict et al., 2010). The other tool recommended
14

by the American Association of Medical Physicists (AAPM) Task Group (TG)-101 is an optical
surface monitoring system. The open-faced Encompass mask allows for the surface monitoring
system to survey the top portion of the patient’s face for motion during beam delivery. Any
detected patient motion at the time of beam delivery could compromise the integrity of the
treatment, which is why this is a necessary tool. The surface monitoring system currently utilized
for patient monitoring in St. George is AlignRT. This surface monitoring system uses nonionizing visible light to create a three-dimensional surface structure that is matched to the
reference surface obtained from CT simulation data. There is a constant feedback of patient
surface location during their treatment and, if at any point a displacement greater than 1 mm or 1
degree is detected, the beam can be manually stopped, and the patient can be repositioned. In the
case of SRS treatments, the assumption is made that the external surface correlates with the
internal tumor motion.
An analysis of the AlignRT system in St. George was done to test this assumption. It was
found that the necessary shifts suggested by the AlignRT systems were identical to the suggested
shifts needed to properly align the CBCT to the CT simulation images using the auto registering
tool. It is important to note that AlignRT has been reviewed and used in a vast number of clinics
for over a decade. Many SRS specific studies have made positive conclusions that this tool can
confidently be used for submillimeter motion tracking during SRS delivery (Wiersma et al.,
2013). Recently, a group of medical physicists at the University of Alabama Birmingham
preformed a detailed analysis of their AlignRT surface monitoring system and found that it was
doing an adequate job of patient monitoring and could confidently be utilized with normal SRS
delivery and HyperArc automated delivery, which support the findings at the St. George system
(Covington et al., 2020).
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Although proper monitoring of the patient can be visualized using this tool. It was also
necessary to consider if the tolerances of 1 millimeter and 1 degree of rotation were acceptable
for preserving the integrity of the treatment delivery. Using a CT simulation image, four targets
with one-centimeter diameter were placed at random locations within the brain of the STEEV
phantom. A HyperArc plan was created to deliver 24 Gy to each target. The outcome of this plan
was used as the control. The same image set was then rotated 0.5, 1.0, 1.5, and 2.0 degrees from
the original images. Utilizing the same treatment plan, dose was recalculated to evaluate what
effect each magnitude of rotation would have on prescription dose coverage.

Figure 7. D99% for 1 cm diameter targets at various distances from the isocenter
with increased degrees of rotation.
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As shown in Figure 7, rotational errors do have an impact on target coverage. Planning
target volume (PTV) D is the largest target to isocenter distance and the dose coverage is
inadequate even for the control. This is a possible trade off to having large distances between
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isocenters and targets if no other adjustments to the plan are applied. The other PTVs did meet
the necessary prescription dose coverage for 0.5- and 1-degree rotational differences. This
provides the necessary information to conclude that a 1 degree tolerance is appropriate to ensure
that plan integrity is intact and while there are deviations from the planned dose at 0.5 degrees,
they are not significant enough to support the need for a reduction in tolerance at this time.

Small Field Dosimetry
Physics of Small Field Dosimetry
Small fields allow for conformal treatments to small target regions within the body but
pose a significant challenge for verification of the radiation dose during the quality assurance
process. The loss of lateral charged particle equilibrium (LCPE) and partial source occlusion are
beam related conditions that produce a pronounced drop in beam output for small field sizes
(Palmans et al., 2018). Lateral charged particle equilibrium occurs when electrons traveling
laterally from the photon beam are equally replaced by secondary electrons traveling into the
beam. The loss of LCPE can be seen along the central axis of narrow photon beams if the radius
of the beam is smaller than the lateral range of the secondary electrons. Li et al. (1995) first
defined the minimum radius of a photon beam or the lateral charged-particle equilibrium range,
which is expressed as the ratio of absorbed dose to collision kerma. For a 6 MV photon beam the
minimum range for achieving LCPE is approximately 1.2 cm.
Partial source occlusion is the result of the primary photon beam being blocked by
collimators, such as jaws and MLCs, to a field size smaller than the dimensions initially
produced by the target, which is typically around one millimeter for a Varian TrueBeam linear
accelerator (Das et al., 2021). For large field sizes, the fifty percent isodose line of the beam
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profile, which is the full-width half maximum (FWHM), defines the field size. In this case the
FWHM is roughly the same size as the collimator position. With small field sizes there is a lack
of congruence between the FWHM and the collimator position. To account for this the FWHM is
located at lower isodose levels and will result in an overestimation of the field size (Das et al.,
2008). In brief, partial source occlusion is a result of an overlap in the penumbra region,
reduction in dose along the central axis of the photon beam and widening of the field size
(Andreo, 2018).
Small field sizes are not only controlled by machine settings, they are also defined by the
detector used to measure them. Selecting the correct measurement tool is key for acquiring the
most accurate dosimetric data. With any radiation measurement tool, the output signal is the
measurement averaged over the entire sensitive volume of the detector (Palmans et al., 2018).
With small fields, the detector may be larger than the actual field size or the beam may only
cross part of the sensitive volume, shrouding the shape of the dose distribution by reporting a
mean absorbed dose reading. This is called volume averaging. Volume averaging also occurs in
areas where there is high dose gradients and inconsistent particle fluence over the sensitive
volume, e.g. with flattening filter free (FFF) beams (Andreo, 2018). To minimize the effects of
volume averaging a detector with a sufficiently small sensitive volume should be selected. An
investigation of the patient specific quality assurance tools available in St. George was
completed for increasing isocenter to target distance HyperArc plans with automated beam
delivery.
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Measurement Devices
STEEV

Figure 8. Image of the CIRS STEEV phantom and inserts.

The tool utilized for much of the process of HyperArc off axis target verification was a
phantom specifically designed by Computerized Imaging Reference Systems (CIRS) for
stereotactic end-to-end verification (STEEV) shown in Figure 9. STEEV is an anthropomorphic
phantom made from a tissue-equivalent material and has details such as bones, brain, spinal cord,
teeth and sinuses allowing for the most accurate representation of absorbed dose as would be
expected in a human being (Phantom Patient for Stereotactic End-to-End Verification. ). This
phantom has a multitude of inserts that fit into the brain region and allow for different types of
QA procedures to be tested. For the HyperArc dosimetric verification, the ion chamber
positioning cube and the film cube were utilized. These inserts supported a reproducible process
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which increased confidence in experimental conclusions that will be discussed in the following
sections.

Ion Chamber
Ion chambers are the most widely used radiation detection tool for in beam measurements
to verify that the dose intended is delivered properly (Khan & Gibbons, 2014). In general,
ionization chambers generate an output by applying an electric field to two electrodes that are
responsible for collecting ion pairs created by the interaction of radiation and the gas that fills the
chamber’s sensitive volume. The charge collected from the production of ion pairs in the
chamber is proportional to the output response because the operating voltage does not allow the
formation of secondary electrons after an ionization event occurs (Mayles et al., 2007). There are
a wide variety of ion chambers with different geometric traits that make them suitable for many
different applications. For the dosimetric verification within the radiation field of HyperArc
plans delivered with automation, the Exradin A16 cylindrical pinpoint chamber was utilized and
will be the focus of discussion. A schematic of the A16 chamber is provided in Figure 9.

Figure 9. Schematic of the Exradin A16 ionization chamber.
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The Exradin A16 chamber has a collecting volume of 0.007 cm3 making it ideal for use
in verification of SRS plans (Bhatnagar et al., 2010). The central electrode and shell of this
chamber are made of Shonka C552, an air-equivalent plastic. The air-equivalence is an important
trait because some small volume chambers have a high-density material like steel for their
central electrode which produces larger amounts of secondary radiation thus increasing the
chamber output (Low et al., 2011). The cylindrical design of the A16 chamber minimizes the
variation in response as long as the chamber is perpendicular to the beam. In the case of
assessing the most accurate absorbed dose for patient specificity the most realistic plan delivery
needs to be utilized. Doing this results in beam trajectories delivering dose to the chamber at
oblique angles. The sensitivity of the chamber at these angles was experimentally determined
due to the lack of published literature on the directional dependence of the Exradin A16
ionization chamber (Miften et al., 2018).
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Figure 10. Depiction of the experimental set-up to determine the directional
dependence of the Exradin A16 ionization chamber.

The chamber and gantry orientation to quantify the directional dependence of the A16
reference chamber is shown in Figure 10. The chamber was oriented perpendicular to the beam
at a gantry angle of zero degrees. 200 monitoring units (MU) were delivered for 2x2, 3x3, and
4x4 cm2 field sizes. Figure 11 shows a plot of the output measurements taken at each gantry
angle. They exhibited a stable output once the gantry reached zero degrees. Prior to this angle, a
portion of the detector's stem was irradiated, introducing more leakage current and increasing the
absorbed dose output. This is called the stem effect and is the reason there is an unstable
response from 315 degrees to 0. The stem effect occurs when a portion of the detector's stem is

22

irradiated, introducing more leakage current and increasing the absorbed dose output (Low et al.,
2011).

Figure 11. Outcome of the directional dependence measurements of the
Exradin A16 ionization chamber.

The confidence in detector stability at oblique angles allowed for the most realistic plan
delivery with gantry, collimator, and couch motion able to be utilized to assess dose to the A16
chamber. Prior to treatment planning, a CT simulation scan was done with the A16 chamber
placed in the STEEV phantom (Figure 12). This was done to get the most accurate location of
the sensitive volume of the chamber. Using that planning CT, HyperArc plans were created for a
one-centimeter diameter target with varying isocenter distance. A reference point was added to
the center of the sensitive volume of the chamber. The treatment planning system (TPS)
calculated dose to this reference point was used as a comparison to the measured A16 dose. Prior
to taking phantom measurements a 200 MU baseline measurement was taken in reference
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conditions to establish the nC to Gy conversion. After that was completed, the simulation set up
was reproduced and a CBCT of STEEV was taken for the most accurate alignment of the
phantom and the plan was delivered. The nC output was recorded and converted to absorbed
dose, from which a percentage difference was calculated between the predicted TPS dose and
measured dose.

Figure 12. Planning CT used for ion chamber measurements.

.

As Table 1 shows, each of the plans produced chamber measurements within tolerance of
the expected TPS value. Some sources of error that may have occurred are the ability to have
precision set up of the STEEV phantom and having an identical chamber location to the one set
in the simulation process. Also, an unavoidable error is introduced with gantry, couch, and
collimator walk out: the TrueBeam in St. George has an isocenter size of approximately 0.4
millimeters reported via the extended couch machine performance check (MPC) report, which is
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completed prior to all HyperArc treatments. Although acceptable results were obtained using the
Exradin A16 chamber, one-dimensional ionization point measurements alone are not a sufficient
way to detect errors in VMAT plan delivery because of the limited amount of information they
provide about the entire treatment plan. Therefore, it is common practice to use film in
conjunction with the ion chamber to provide a two-dimensional dose plane of the treatment plan
(Miften et al., 2018).

Table 1. Comparison between ion chamber measurement and TPS calculated
dose for increasing isocenter to target distance.
Distance
from
Percentage
Isocenter
difference
(cm)
Control
2.4%
1
1.1%
2
1.8%
3
1.8%
4
2.0%
5
1.0%
6
2.9%
7
2.0%
8
2.8%
9
2.3%
10
2.5%

Gafchromic Film
The evolution of self-developing radiochromic film occurred simultaneously with the
development of radiation absorption materials (Niroomand-Rad et al., 1998). The development
of the chemical structure was pioneered by William McLaughlin in 1965 while he was working
for the National Institute of Standards and Technology (NIST) (Pai et al., 2007). The free-

25

radical medium he created was a combination of a natural photopolymer with leuco dyes. The
photopolymer changes its molecular structure when exposed to ionizing radiation. It is during
this transformation that there is a release of the leuco dye from microcapsules in the
photopolymer. Leuco dyes have the capability of changing between two different chemical
states. One chemical state is colorless and the other typically produces varying shades of blue
after exposure to electromagnetic radiation that is proportional to the amount of absorbed dose
imparted on the film.
More recently, photopolymer films were replaced by a new compound, polydiacetylene,
introduced in the 1980’s by David Lewis who was associated with International Specialty
Products (ISP) (Soares et al., 2009). Polydiacetylene has a near tissue equivalency and has low
sensitivity to the visible light spectrum making them much easier to handle (Devic, 2011). Even
though the chemical makeup of these films is different from the original photopolymer
radiochromic film, the process of acquiring a dose distribution map is the same.

Figure 13. Schematic of the GAFCHROMIC EBT-XD film.
Matte Surface Clear Polyester Base, 125 µm
Active Layer, 25 µm
Matte Surface Clear Polyester Base, 125 µm

The film starts as a yellowed, thin plastic sheet and exposed areas turn various shades of
blue depending on the amount of dose that has been absorbed. Initially, these films had a single
polymer layer that was compatible with specific energy ranges but were not applicable in a
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clinical setting because they required around 50 Gy of dose for accurate measurements. A double
layer polymer design replaced the single layer films allowing for accurate measurements to be
taken with a significant reduction in absorbed dose. A schematic of the GAFCHROMIC EBTXD film utilized for special resolution analysis is shown in Figure 14.
EBT-XD film has a dynamic range of 0.1 to 60 Gy with an ideal range of 0.4 to 40 Gy,
which is a trait that lends itself well to analyzing SRS type plans (Miura et al., 2016). The
composition of the active layer, as described above, has less than a five percent energy
dependence, dose fraction response, and dose rate response. Radiochromic film has a dose
accuracy of two to three percent because it is tissue equivalent material. More importantly, the
high spatial resolution (approximately 25 micrometers) of radiochromic film allows for
validation of the integrity of the 6DoF couch with increasing isocenter distance from the target
volume.

Figure 14. Outcome of the GAFCHROMIC EBT-XD film calibration.
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The use of film for the analysis of spatial accuracy is a tedious process that if
done correctly, can give well informed results. Calibration of the film is a necessary first step
(Figure 14). Film exposure is completed under reference conditions, such that 1 MU is equal to 1
cGy. After 24 hours, the film is then scanned into the RIT film software using an Epson
10000XL flatbed scanner. It is in this step that the optical density of the film is related to dose.
To assess spatial resolution, the EBT-XD film was cut to the size of the STEEV film insert and
labeled for set-up consistency. HyperArc plans were created for targets with a 1- and 3centimeter diameter at a selected isocenter location as controls, HyperArc plans were then
created form the two targets at isocenters of 2, 4, 6, 8, and 10 centimeters from the control
isocenter. At the time of exposure, a CBCT was used to get the best film alignment, which was
inside of the STEEV phantom, prior to irradiation of the film. Twenty-four hours later, the film
was scanned using the same flatbed scanner and scanning protocol as the calibration film. For
comparison, the dose plane that correlated to the location and size of the film was exported from
Eclipse (Figure 15). Using the film software, a manual registration was completed by selecting
corresponding registration points at the corners of the film and dose plane. Manual registration
ensured that the results determined by the software were the most accurate measure of the actual
dose delivered to the film without hiding any possible errors. From this registration a vertical and
horizontal graphical comparison of the two images were produced and a gamma pass rate from
the pixel map using 5%/1mm gamma analysis was recorded.
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Figure 15. EBT-XD film exposure and corresponding TPS dose plane

A gamma pass rate takes both the dose difference and the distance-to-agreement (DTA)
into account making it a useful tool for assessment of both dose gradients and homogeneity
(Miften et al., 2018). Clinically, any gamma pass rate less than ninety percent is deemed
unacceptable. The gamma pass rates for both the one- and three-centimeter diameter targets
produced pass rates ranging from approximately 90 to 98% (Table 2). Figure 16 shows a
comparison between 98 percent and a 90 percent gamma pass rate. Much of the failing area is
located at the edges of the film were artifacts occurred.
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Table 2. Gamma pass rates for a 3- and 1-centimeter diameter target
at increasing isocenter distance.
Distance from
Target Size
Isocenter (cm)
1 cm
3 cm
Control
93.10
93.68
2
97.97
91.24
4
91.22
90.07
6
98.59
95.14
8
97.92
93.02
10
91.84
97.17

Table 3 provides a comparison of the auto registration feature for the one-centimeter
diameter plans. While the values for the gamma pass rates of the manual and auto registration
were similar, they were not the same. This alludes to the idea that there are slight positional
errors present with the manual registration (Figure 17). Upon further investigation of the visual
alignment vertically and horizontally, approximately a one-millimeter vertical offset was
detected for all the irradiated film, shown in image A of Figure 17. Due to the nature of film
measurements, small errors in film size or phantom set up most likely provided the greatest
source of error. Possible fixes for this would be to choose a region of interest that omitted the
edges of the film where much of the disagreement between the TPS and delivered dose occurred
and to also utilize the precision cut film specifically designed for the corresponding STEEV
insert.
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Table 3. Comparison between manually registered and auto registered EBT-XD film with a 1centimeter target size at increasing target to isocenter distances.
Distance from
Gamma pass
Gamma pass
Percent
Isocenter (cm)
rate manual
rate automatic
difference
Control
93.10
96.53
3.55%
2
97.97
97.79
-0.18%
4
91.22
97.06
6.02%
6
98.59
99.00
0.41%
8
97.92
97.81
-0.11%
10
97.17
96.84
-0.34%

Figure 16. Gamma pass/fail plot on the reference image where the red indicates
a gamma index value greater than 1 A) passing rate of 90.07 B) passing rate of 98.59.

As was previously determined in the geometric review, plans with minimal errors could
have a high impact on dosimetric outcomes and much of the literature examining the plausibility
of HyperArc utilization negates the use of a 6DoF couch. From the gamma pass rate data and
visual vertical and horizontal continuity of the film to the treatment planning system dose plane,
not accounting for the ability to correct for geometric errors is misleading. Kraft et al. (2021),
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provided data that showed no loss of local control for targets with increasing distances from
isocenter with a 6DoF couch correction prior to treatment and patient monitoring during beam
delivery. This supports the finding of the gamma pass rates being within tolerance for the patient
specific QA even with a target distance ten centimeters away from isocenter.

Figure 17. Vertical alignment differences between the (a) manual and (b) auto registration for the
1-centimeter diameter target at 6 cm from isocenter.

Electronic Portal Imaging Device
The use of an ion chamber and film for the verification of patient specific QA is a widely
accepted method. Another option for 2-dimensional measurements of patient specific QA is
portal dosimetry (Low et al., 2011). Portal dosimetry utilizes the megavoltage (MV) detector,
referred to as the Electronic Portal Imaging Device (EPID), that is attached to the LINAC to
create a digital fluence map of the delivered verification plan. This process simplifies patient
specific QA and gives the user the ability to assess the dosimetry and mechanical function
quickly and with an appreciative amount of detail.
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Figure 18. Schematic of the electronic portal imaging device.
Metal plate

Phosphor screen

a-Si active region

The Varian TrueBeam is equipped with an amorphous silicon flat panel detector (a-Si
1000). The schematic of the detector is provided in Figure 17. The copper plate produces
Compton electrons from the incident MV photon beam followed by a phosphor screen to absorb
any of the high energy photons that did not interact with the copper or were produced by further
interaction of the Compton electrons. The light sensing panel holds photodiodes and thin film
transistors (TFT) to convert the electron energy into a light output that is proportional to the
photon energy imparted on the detector’s surface. The aSi-1000 is a 40.14 by 30.11 cm2 detector
that has 1024 x 768 pixels. Each pixel is 0.39 mm2 which accounts for the high resolution of this
detector.
The advantage of doing patient specific QA with the EPID is the simplicity from set-up
all the way through analysis and storage of the outcome. The drawback is that the EPID and
portal dosimetry software is vendor provided and does create a debate within the medical physics
community about its usability as an independent verification tool. A 2016 point/counterpoint
debate examined this exact topic (Mutic et al., 2016). The point being made is that the EPID and
other components of the LINAC are independent of each other even though they are connected
to the same machine and because of their superior performance to all other QA devices they
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should be used. In St. George, the EPID performance has been evaluated and is used as a tool for
patient specific QA with a high degree of confidence.
The same HyperArc plans that were used for the ion chamber dosimetric measurements
were converted into verification plans using the portal dosimetry standardized protocol. Each
field was delivered on the TrueBeam and then assessed in the portal dosimetry workspace. Three
different gamma analysis criteria were used to assess each delivered field, 3%/3mm, 5%/1mm
and 1%/1mm. Gamma pass rates for each of these analyses was compiled and an assessment of
the plan was completed.

Figure 19. Visual representation of the gamma analysis for tolerances: A) 3%/3mm,
B) 5%/1mm, and C) 1%/1 mm

Proper plan assessment with portal dosimetry is reliant on the tolerances set for the
gamma criteria (Figure 18). The 3%/3mm is the most common utilized guideline for IMRT
patient specific QA. For the treatment plans evaluated, this metric provided little information
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regarding possible areas that were lacking agreement. TG-218 suggests using tighter gamma pass
rate tolerances for SRS treatments (Miften et al., 2018). The 1%/1mm was the most stringent
criteria and shows many of the fields passing. The highest deviations from agreement were found
with the plans that had larger target to isocenter distances, with the lowest gamma pass rate being
88.7% for field 4 of the ten-centimeter distance. Although this seems like a logical metric to use
given the nature of SRS treatments, the high resolution detector and the strict assessment metric
leads to a large amount of inconsistency with the pass rate. A gamma criterion of 5%/1mm takes
advantage of what is most desirable for SRS treatment delivery. The 5% dose tolerance is less
rigid. Dose difference does not estimate regions of the steep dose gradients very well and strict
agreement to where dose agrees is less important because of the ablative nature of SRS. The
DTA however assesses non uniform regions best and shows that a 1 mm tolerance is best for
measuring the dose distribution between the delivered and calculated dose. Upon analysis of the
various isocenter plans with the 5%/1mm gamma criteria, the TrueBeam in St. George can
properly deliver each of the plans with the necessary precision.

Conclusion
The currently utilized one millimeter or 1-degree tolerances for the surface guidance
system are adequate for producing and delivering HyperArc plans with acceptable precision even
when automated delivery is utilized. Assessing these plans using portal dosimetry gives a result
similar to that of an ion chamber and EBT-XD film for patient specific HyperArc QA verifying
the confidence of treatment delivery for off-axis targets up to 10 cm. Overall, this project
confirmed current methodology being utilized clinically and established additional confidence in
the use of HyperArc for patients that present challenging multi-target SRS treatments.
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